China Resources Pharmaceutical Group Limited (FRA:640)
Germany
· Delayed Price · Currency is EUR 0.5350
+0.0050 (0.94%)
At close: Apr 17, 2025, 10:00 PM CET
FRA:640 Revenue
In the year 2024, China Resources Pharmaceutical Group had annual revenue of 257.67B CNY with 5.30% growth. China Resources Pharmaceutical Group had revenue of 129.08B in the half year ending December 31, 2024, with 20.66% growth.
Revenue
257.67B CNY
Revenue Growth
+5.30%
P/S Ratio
0.10
Revenue / Employee
3.54M CNY
Employees
72,700
Market Cap
3.53B EUR
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 257.67B | 12.97B | 5.30% |
| Dec 31, 2023 | 244.70B | 26.52B | 12.16% |
| Dec 31, 2022 | 218.18B | -18.62B | -7.86% |
| Dec 31, 2021 | 236.81B | 36.38B | 18.15% |
| Dec 31, 2020 | 200.42B | -4.03B | -1.97% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 34.18B |
| Deutsche Telekom AG | 118.43B |
| Siemens Aktiengesellschaft | 76.54B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 9.75B |
| Deutsche Börse AG | 5.80B |
| Merck KGaA | 21.16B |